Riverhead Capital Management’s Avanos Medical AVNS Stock Holding History

Riverhead Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$126K	Hold	3,354	–	–	﹤0.01%	1272
2019 Q2	$146K	Hold	3,354	–	–	0.01%	1252
2019 Q1	$143K	Hold	3,354	–	–	0.01%	1235
2018 Q4	$150K	Hold	3,354	–	–	0.01%	1183
2018 Q3	$230K	Buy	+3,354	New	+$216K	0.01%	1139
2018 Q2	–	Sell	-4,154	Closed	-$191K	–	1546
2018 Q1	$191K	Hold	4,154	–	–	0.01%	1086
2017 Q4	$192K	Buy	4,154 +600	+17%	+$27.6K	0.01%	1091
2017 Q3	$160K	Buy	3,554 +357	+11%	+$15.2K	0.01%	1088
2017 Q2	$126K	Buy	3,197 +1,497	+88%	+$56.6K	0.01%	1129
2017 Q1	$65K	Hold	1,700	–	–	﹤0.01%	1181
2016 Q4	$63K	Hold	1,700	–	–	﹤0.01%	1164
2016 Q3	$59K	Sell	1,700 -5,648	-77%	-$198K	﹤0.01%	1122
2016 Q2	$192K	Sell	7,348 -977	-12%	-$29.9K	0.01%	921
2016 Q1	$239K	Sell	8,325 -2,775	-25%	-$73.9K	﹤0.01%	1194
2015 Q4	$371K	Buy	11,100 +8,200	+283%	+$255K	0.01%	1040
2015 Q3	$82K	Buy	+2,900	New	+$101K	﹤0.01%	1160

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverhead Capital Management's AVNS Position: Q3 2019 in Review

Riverhead Capital Management held its Avanos Medical (AVNS) position steady in Q3 2019 at 3,354 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1272.

Riverhead Capital Management first reported a position in AVNS in Q3 2015 and has held it in 16 quarters since. The position peaked at $371K in Q4 2015. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Riverhead Capital Management held 3,354 shares of Avanos Medical worth $126K as of Q3 2019.
Riverhead Capital Management left its Avanos Medical share count unchanged in Q3 2019.
Avanos Medical made up ﹤0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1272 holding.
Riverhead Capital Management first reported a position in Avanos Medical in Q3 2015 and has held it in 16 quarters since.
Riverhead Capital Management's Avanos Medical position peaked at $371K in Q4 2015.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.